Calcineurin A-α but not A-β is required for normal kidney development and function

被引:61
作者
Gooch, JL
Toro, JJ
Guler, RL
Barnes, JL
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med, Div Nephrol, San Antonio, TX 78229 USA
[2] S Texas Vet Hlth Care Syst, Audie Murphy Div, San Antonio, TX USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0002-9440(10)63430-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Calcineurin is an important signaling molecule in the kidney and may be involved in a variety of processes. The phosphatase subunit of calcineurin (CnA) has three isoforms, alpha, beta, and gamma. In this study, we investigated the effect of loss of calcineurin A-alpha (CnA-alpha) or calcineurin A-beta (CnA-beta) on the development and function of the kidney. Total calcineurin expression and activity was significantly reduced in whole kidney homogenates from both CnA-alpha -/- and CnA-beta -/- mice. Kidneys of CnA-beta -/- mice appear normal and the mice develop with no phenotypic abnormalities. in contrast, kidneys of CnA-alpha -/- animals fail to fully develop. in particular, postnatal maturation of the nephrogenic zone (NZ) is defective. Within the NZ, glomeruli also fail to mature and lack mesangial cells. In addition to alterations in development, there is an absence of proliferation and an increase of cell death in the NZ with loss of CnA-alpha. Finally, increased collagen deposition is observed and serum creatinine levels are significantly increased in CnA-alpha -/- animals compared to wild-type littermates, indicating that kidney function is impaired. In summary, absence of CnA-alpha but not CnA-beta leads to a defect in normal maturation of the NZ and glomeruli, alterations in the cell cycle, and impaired kidney function.
引用
收藏
页码:1755 / 1765
页数:11
相关论文
共 36 条
  • [1] Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis
    Brantley, JG
    Sharma, M
    Alcalay, NI
    Vanden Heuvel, GB
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (04) : 1240 - 1248
  • [2] Defective T cell development and function in calcineurin Aβ-deficient mice
    Bueno, OF
    Brandt, EB
    Rothenberg, ME
    Molkentin, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) : 9398 - 9403
  • [3] Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice
    Bueno, OF
    Wilkins, BJ
    Tymitz, KM
    Glascock, BJ
    Kimball, TF
    Lorenz, JN
    Molkentin, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (07) : 4586 - 4591
  • [4] Chan VSF, 2002, EUR J IMMUNOL, V32, P1223, DOI 10.1002/1521-4141(200205)32:5<1223::AID-IMMU1223>3.0.CO
  • [5] 2-5
  • [6] Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery
    Chang, CP
    McDill, BW
    Neilson, JR
    Joist, HE
    Epstein, JA
    Crabtree, GR
    Chen, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07) : 1051 - 1058
  • [7] Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney
    Combs, HL
    Shankland, SJ
    Setzer, SV
    Hudkins, KL
    Alpers, CE
    [J]. KIDNEY INTERNATIONAL, 1998, 53 (04) : 892 - 896
  • [8] Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo - An apoptosis-independent model of dilated heart failure
    De Windt, LJ
    Lim, HW
    Taigen, T
    Wencker, D
    Condorelli, G
    Dorn, GW
    Kitsis, RN
    Molkentin, JD
    [J]. CIRCULATION RESEARCH, 2000, 86 (03) : 255 - 263
  • [9] Fruman David A., 1996, Methods (Orlando), V9, P146, DOI 10.1006/meth.1996.0020
  • [10] Garver TD, 1999, MOL PHARMACOL, V55, P632